Skip to main content
OpenTrials

Clinical trial condition

Lipid Metabolism Disorders

Explore clinical trials studying Lipid Metabolism Disorders. Study availability and eligibility vary by location and protocol.

3,309 public trials 330 recruiting studies
Refine in advanced search Browse all conditions

Lipid Metabolism Disorders trial results

Completed

The Efficacy and Safety of Triple Therapy of Telmisartan/Amlodipine/Rosuvastatin

NCT03860220

Conditions
Cardiovascular Diseases, Dyslipidemias, Hypertension, +4 more
Locations
  • Kangwon National University Hospital Chuncheon, Gangwon-do, South Korea
  • Korea University Ansan Hospital Ansan, Gyeonggi-do, South Korea
  • Hallym University Sacred Heart Hospital Anyang-si, Gyeonggi-do, South Korea
  • CHA Bundang Medical Center, CHA University Seongnam-si, Gyeonggi-do, South Korea
View Trial Details
Completed

A Study of Olezarsen (Formerly Known as AKCEA-APOCIII-LRx) in Adults With Hypertriglyceridemia and Atherosclerotic Cardiovascular Disease (Established or at Increased Risk for), and/or With Severe Hypertriglyceridemia

NCT05355402

Conditions
Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +10 more
Locations
  • Clinical Trials Research Lincoln, California, United States
  • Catalina Research Institute, LLC Montclair, California, United States
  • Excel Medical Clinical Trials, LLC Boca Raton, Florida, United States
  • De La Cruz Research Center Miami, Florida, United States
View all 24 locations
View Trial Details
Completed

An Efficacy and Safety Study of HGT-1110 in Participants With Metachromatic Leukodystrophy

NCT01887938

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
Locations
  • The Children's Hospital at Westmead Westmead, Australia
  • Hospital de Clinicas de Porto Alegre Porto Alegre, Brazil
  • Detska Interni Klinika, Lf Mu A Fn Brno Brno, Czechia
  • Rigshospitalet Copenhagen, Denmark
View all 15 locations
View Trial Details
Completed

A Non-interventional Implementation Study to Evaluate Treatment With Inclisiran (Leqvio®) and Other Lipid Lowering Treatments in a Real-world Setting

NCT05362903

Conditions
Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +8 more
Locations
  • Novartis Investigative Site Freudenstadt, Baden-Wurttemberg, Germany
  • Novartis Investigative Site Heidelberg, Baden-Wurttemberg, Germany
  • Novartis Investigative Site Kirchheim unter Teck, Baden-Wurttemberg, Germany
  • Novartis Investigative Site Konstanz, Baden-Wurttemberg, Germany
View all 121 locations
View Trial Details
Completed

Study of Efficacy, Safety, Tolerability and Quality of Life of Inclisiran (KJX839) vs Placebo, on Top of Ongoing Individually Optimized Lipid-lowering Therapy, in Participants With Hypercholesterolemia

NCT05192941

Conditions
Angina Pectoris, Arterial Occlusive Diseases, Arteriosclerosis, +18 more
Locations
  • Novartis Investigative Site Sofia, Bulgaria
  • Novartis Investigative Site Burgas, Bulgaria
  • Novartis Investigative Site Burgas, Bulgaria
  • Novartis Investigative Site Gabrovo, Bulgaria
View all 136 locations
View Trial Details
Completed

Cluster Randomized Trial of a Digital Quality Improvement Intervention on LDLCholesterol Control

NCT05622929

Conditions
Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +6 more
Locations
  • Hospital da Bahia Salvador, Estado de Bahia, Brazil
  • Hospital Santa Lúcia Poços de Caldas, Minas Gerais, Brazil
  • Hospital e Maternidade Angelina Caron Campina Grande do Sul, Paraná, Brazil
  • Hospital Regional Hans Dieter Schmidt Joinville, Santa Catarina, Brazil
View all 28 locations
View Trial Details
Completed

Dose-Ranging Study of ST-920, an AAV2/6 Human Alpha Galactosidase A Gene Therapy in Subjects With Fabry Disease (STAAR)

NCT04046224

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
Locations
  • University of California, Irvine Irvine, California, United States
  • University of South Florida Tampa, Florida, United States
  • Emory University School of Medicine Atlanta, Georgia, United States
  • Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States
View all 18 locations
View Trial Details

Related conditions